3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate(CAS: 37413-91-5)

This compound requires adherence to regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for the European Union, and FDA and EPA requirements for handling and disposal in the United States. Specific documentation and safety measures are necessary to ensure compliance with these regulations.

While 3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate is a specific compound, alternatives such as related steroid acetates or other synthetic intermediates can be explored. Common substitutes include progesterone acetate or testosterone acetate, which may serve similar functions in certain applications.

Research trends for this compound are focused on its potential applications in pharmaceuticals, particularly in hormone therapy and research. Market demand is influenced by ongoing interest in steroid derivatives and their uses in medical treatments. Emerging trends include advancements in drug delivery systems and personalized medicine.

Waste containing this compound should be handled through professional waste disposal services, following local regulations. Proper collection in sealed containers, followed by incineration or other appropriate methods, is essential to prevent environmental contamination. Safety precautions, such as proper labeling and training, are crucial during handling and disposal to ensure environmental and occupational safety.